Recent innovations in mRNA vaccines
Highlights • mRNA vaccines continue to show promise as prophylactic and therapeutic vaccines. • Clinical data with mRNA cancer vaccines indicate they are tolerated and immunogenic. • Self-amplifying mRNA vaccine are potent in larger animal at low doses (50 μg). • A broader package of human clinical...
Gespeichert in:
Veröffentlicht in: | Current opinion in immunology 2016-08, Vol.41, p.18-22 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Highlights • mRNA vaccines continue to show promise as prophylactic and therapeutic vaccines. • Clinical data with mRNA cancer vaccines indicate they are tolerated and immunogenic. • Self-amplifying mRNA vaccine are potent in larger animal at low doses (50 μg). • A broader package of human clinical proof of principle still needs to be developed. |
---|---|
ISSN: | 0952-7915 1879-0372 |
DOI: | 10.1016/j.coi.2016.05.008 |